GlassScriptPhysician profile
Rachel Holcomb
NPI 1831502269
$683.74
in general payments reported to CMS, 2019-2025
14 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $51.38 · 2022: $20.22 · 2023: $33.33 · 2024: $256 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $166.53 | 2019-2025 | Doc Band |
| Pfizer INC. | $128.92 | 2019-2025 | |
| Corium, LLC | $90.10 | 2024-2025 | Azstarys |
| Sanofi Pasteur INC. | $60.40 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $44.50 | 2022-2024 | Vaxneuvance, Vaxelis, Rotateq |
| Biomarin Pharmaceutical INC. | $26.12 | 2024 | Voxzogo 1.2mg |
| Genentech USA, INC. | $24.38 | 2020 | |
| Verrica Pharmaceuticals INC. | $24.31 | 2024 | Ycanth |
| Hologic Sales and Service, LLC | $24.23 | 2024 | Aptima |
| Ars Pharmaceuticals Operations, INC. | $24.22 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $23.82 | 2024 | |
| Kaleo, INC. | $16.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.07 | 2025 | Zoryve |
| Ultragenyx Pharmaceutical INC. | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Holcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.